Verve Therapeutics (VERV) News Today → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free VERV Stock Alerts $6.41 +0.26 (+4.23%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVerve Therapeutics (NASDAQ:VERV) Trading Up 7.8%marketbeat.com - May 3 at 9:33 PMVerve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - May 3 at 4:01 PMVerve Therapeutics (NASDAQ:VERV) Reaches New 12-Month Low at $5.93americanbankingnews.com - May 3 at 5:20 AMVerve Therapeutics (NASDAQ:VERV) Sets New 1-Year Low at $5.93marketbeat.com - May 1 at 12:28 PMVerve Therapeutics (NASDAQ:VERV) Reaches New 1-Year Low at $6.05americanbankingnews.com - April 27 at 5:32 AMVerve Therapeutics (NASDAQ:VERV) Hits New 52-Week Low at $6.05marketbeat.com - April 25 at 3:44 PMSumitomo Mitsui Trust Holdings Inc. Grows Stock Position in Verve Therapeutics, Inc. (NASDAQ:VERV)marketbeat.com - April 21 at 5:16 AMFederated Hermes Inc. Purchases 1,448,003 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV)marketbeat.com - April 20 at 7:16 AMGV’s Newest Life Sciences General Partner Pursues Precision Treatmentswsj.com - April 18 at 9:55 AMVerve Therapeutics (VERV) Price Target Decreased by 37.88% to 32.77msn.com - April 18 at 12:03 AMVerve Therapeutics (NASDAQ:VERV) Stock Price Down 2.9%marketbeat.com - April 17 at 12:20 PMVerve Therapeutics (NASDAQ:VERV) Sets New 1-Year Low at $7.26marketbeat.com - April 15 at 2:48 PMTop 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarterbenzinga.com - April 11 at 8:46 AMBuy Rating on Verve Therapeutics: Promising Gene Editing Prospects and Anticipated Recoverymarkets.businessinsider.com - April 9 at 8:55 AMA Bold Gene-Editing Solution Began Testing—Then Hit the Strangest Twistmsn.com - April 9 at 8:55 AMVerve Therapeutics (NASDAQ:VERV) Coverage Initiated at HC Wainwrightmarketbeat.com - April 8 at 8:20 AMVerve Therapeutics, Inc. (NASDAQ:VERV) Stock Position Raised by Vanguard Group Inc.marketbeat.com - April 8 at 4:08 AMAfter a Serious Setback, Is Verve Therapeutics a Buy?fool.com - April 6 at 9:50 AMVerve Therapeutics (NASDAQ:VERV) Stock Price Up 4.8%marketbeat.com - April 4 at 2:24 PMJoan Nickerson Sells 1,514 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) Stockinsidertrades.com - April 4 at 7:09 AMGene Editing Experiment Halted as Patient Gets Weird Side Effectsmsn.com - April 3 at 10:43 PMVerve Therapeutics, Inc. (NASDAQ:VERV) Insider Joan Nickerson Sells 1,514 Sharesmarketbeat.com - April 3 at 6:58 PMVerve Therapeutics: An Update On Human CRISPRseekingalpha.com - April 3 at 2:15 PMVerve Therapeutics Stock Remains A Hold After VERVE-101 Enrollment Pauseseekingalpha.com - April 3 at 11:57 AMVerve Therapeutics pauses enrollment of patients in trial for its gene therapy to treat high cholesterol after severe side effectmsn.com - April 2 at 9:34 PMBuy Rating Affirmed for Verve Therapeutics with Strategic Focus on Promising VERVE-102 Programmarkets.businessinsider.com - April 2 at 9:34 PMVerve’s stock tumbles as biotech pauses gene editing trial over safety concernsbizjournals.com - April 2 at 4:34 PMVerve Therapeutics Pauses Enrollment in Trial of Gene Editing Medicine After Serious Adverse Eventmarketwatch.com - April 2 at 11:33 AMVerve Therapeutics To Halt Enrollment In Heart-1 Phase 1b Trial Of VERVE-101; Stock Fallsmarkets.businessinsider.com - April 2 at 11:33 AMVerve drops after pausing enrollments in trial for lead assetmsn.com - April 2 at 11:33 AMVerve Therapeutics stock plunges as cholesterol-lowering gene-editing treatment faces setbackmsn.com - April 2 at 11:33 AMVerve Falls as Gene-Editing Trial Paused on Safety Issuesfinance.yahoo.com - April 2 at 11:33 AMVerve Plunges To Record Low After Cholesterol-Lowering Gene Editor Causes Side Effectsfinance.yahoo.com - April 2 at 11:33 AMVerve Therapeutics (NASDAQ:VERV) Shares Gap Down to $12.79marketbeat.com - April 2 at 11:18 AMVerve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levelsreuters.com - April 2 at 7:30 AMVerve Therapeutics Announces Updates on its PCSK9 Programglobenewswire.com - April 2 at 7:00 AMVerve Therapeutics (NASDAQ:VERV) Trading Down 4.4%marketbeat.com - April 1 at 2:58 PMVerve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 28 at 4:51 PMARK Investment Management LLC Grows Stake in Verve Therapeutics, Inc. (NASDAQ:VERV)marketbeat.com - March 28 at 6:39 AM7 Best Gene-Editing Stocks to Invest in Right Nowmsn.com - March 27 at 3:37 PMWellington Management Group LLP Sells 183,602 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV)marketbeat.com - March 25 at 4:09 AM3 Stocks That Could Be the Next Big Thing in Gene Editinginvestorplace.com - March 21 at 4:19 PMVerve Therapeutics (NASDAQ:VERV) Trading Up 5.7%marketbeat.com - March 21 at 3:52 PMVerve Therapeutics (NASDAQ:VERV) Trading Down 4.9%marketbeat.com - March 18 at 12:44 PMVerve Therapeutics (NASDAQ:VERV) Stock Price Down 3.8%marketbeat.com - March 12 at 1:24 PM'In Vivo' Gene Editing: Adjusting DNA Inside the Body Is Groundbreaking, but Still Riskymsn.com - March 12 at 1:02 AMDoctors Can Now Edit the Genes Inside Your Bodymsn.com - March 11 at 3:02 PMVerve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 1 at 4:01 PMWilliam Blair Comments on Verve Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:VERV)marketbeat.com - March 1 at 6:36 AMNew Forecasts: Here's What Analysts Think The Future Holds For Verve Therapeutics, Inc. (NASDAQ:VERV)finance.yahoo.com - February 29 at 8:46 AM Get Verve Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERV and its competitors with MarketBeat's FREE daily newsletter. Email Address Could Your Accounts Be Frozen? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit VERV Media Mentions By Week VERV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERV News Sentiment▼-0.690.42▲Average Medical News Sentiment VERV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERV Articles This Week▼43▲VERV Articles Average Week Get Verve Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Astria Therapeutics News Today Applied Therapeutics News Today Shattuck Labs News Today Adlai Nortye News Today Arbutus Biopharma News Today KalVista Pharmaceuticals News Today Phathom Pharmaceuticals News Today Oculis News Today COMPASS Pathways News Today Altimmune News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VERV) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
